...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith AGM?

In respect to a listing well thats not going to happen anytime soon,,,,again,,,,hoarding and disrespecting the retail shareholders wishes,,for some reason,,but of course expected!

I'd rather not see a listing. I don't think we'd trade much above RVX.  I'd rather wait for an eventual buyout, though I think that'll be at least a couple years down the road.

Share
New Message
Please login to post a reply